The final resort treatment options of recurrent head and neck cancer

Abstract

Despite treatment, the recurrence rate of head and neck cancers varies between 30 and 50%. More than 50% of the patients with recurrence die, despite rescue therapy. In clinical practice, treatment usually encompasses surgery, radiotherapy, and chemotherapy. However, these methods do not often yield desirable outcomes in patients with recurrence. In this review, we present the final resort methods, except conventional methods used for the treatment of recurrent head and neck cancers in the clinical practice, and their clinical outcomes.

Keywords

• Head and neck cancer, recurrent, treatment

Nüks baş boyun kanserlerinin son tedavi seçenekleri

Abstract

Baş boyun kanserlerinde tedaviye rağmen nüks oranı %30 ila %50 arasında değişmektedir. Nüks görülen hastaların ise %50’den fazlası, kurtarma tedavisine rağmen kaybedilmektedir. Klinik uygulamada tedavi genellikle cerrahi, radyoterapi ve kemoterapiyi kapsamaktadır. Ancak nüks görülen hastalarda bu yöntemler çoğu zaman istenen sonucu verememektedir. Bu derlemede, nüks baş boyun kanserlerinin tedavisinde klinik uygulamada kullanılan yöntemler dışında kalan son yöntemler ve klinik sonuçları sunuldu

Keywords

• Baş boyun kanseri, nüks, tedavi

References

1. Aihara T, Morita N, Kamitani N, Kumada H, Ono K, Hiratsuka J, et al. Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck. Int J Clin Oncol 2014;19:437-44.
2. Zwicker F, Roeder F, Hauswald H, Thieke C, Timke C, Schlegel W, et al. Reirradiation with intensity- modulated radiotherapy in recurrent head and neck cancer. Head Neck 2011;33:1695-702.
3. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000;110:1-18.
4. Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S, et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 2009;75:1493-500.
5. Molin Y, Fayette J. Current chemotherapies for recurrent/metastatic head and neck cancer. Anticancer Drugs 2011;22:621-5.
6. Brockstein BE. Management of recurrent head and neck cancer: recent progress and future directions. Drugs 2011;71:1551-9.
7. Amin M, Glynn F, Rowley S, O'Leary G, O'Dwyer T, Timon C, et al. Complementary medicine use in patients with head and neck cancer in Ireland. Eur Arch Otorhinolaryngol 2010;267:1291-7.
8. Lim CM, Ng A, Loh KS. Use of complementary and alternative medicine in head and neck cancer patients. J Laryngol Otol. 2010;124:529-32.

9. Chen YJ, Kuo JV, Ramsinghani NS, Al-Ghazi MS. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer. Med Dosim 2002;27:171-6.
10. Çakır A, Bilge H. Quality assurance methods for intensity modulated radiotherapy. Türk Onkoloji Dergisi 2013;28:81-90.
11. Sher DJ, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, et al. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 2010;116:4761-8.
12. Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009;73:399- 409.
13. Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007;68:731-40.
14. Studer G, Graetz KW, Glanzmann C. Outcome in recurrent head neck cancer treated with salvage-IMRT. Radiat Oncol 2008;3:43.
15. Biagioli MC, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, et al. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:1067-73.
16. Duprez F, Madani I, Bonte K, Boterberg T, Vakaet L, Derie C, et al. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol 2009;93:563-9.
17. Lin R, Slater JD, Yonemoto LT, Grove RI, Teichman SL, Watt DK, et al. Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy--dose- volume histogram analysis. Radiology 1999;213:489-94.
18. Frank SJ, Selek U. Proton beam radiation therapy for head and neck malignancies. Curr Oncol Rep 2010;12:202-7.
19. Combs SE, Kalbe A, Nikoghosyan A, Ackermann B, Jäkel O, Haberer T, et al. Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region. Radiother Oncol 2011;98:63-7.
20. Fukumitsu N, Okumura T, Mizumoto M, Oshiro Y, Hashimoto T, Kanemoto A, et al. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys 2012;83:704-11.
21. Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2011;81:1473-8.
22. Mizoe JE, Tsujii H, Kamada T, Matsuoka Y, Tsuji H, Osaka Y, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:358-64.
23. Micke O, Schäfer U, Prott FJ, Schüller P, Scheuber M, Willich N. Fast neutron irradiation in advanced pre-irradiated head and neck tumors. Tumori 2000;86:393-8.
24. Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, et al. Boron neutron capture therapy in the treatment of locally recurred head-and- neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys 2012;82:67-75.
25. Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:475-82.
26. Fuwa N, Suzuki M, Sakurai Y, Nagata K, Kinashi Y, Masunaga S, et al. Treatment results of boron neutron capture therapy using intra-arterial administration of boron compounds for recurrent head and neck cancer. J Radiol 2008;81:749-52.
27. Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, et al. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J Clin Oncol 2010;33:286-93.
28. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL, et al. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2009;74:1348-55.
29. Cengiz M, Özyiğit G, Yazici G, Doğan A, Yildiz F, Zorlu F, et al. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int J Radiat Oncol Biol Phys 2011;81:104-9.
30. Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R, et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 2006;5:529-35.
31. Kawaguchi K, Sato K, Horie A, Iketani S, Yamada H, Nakatani Y, et al. Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol 2010;5:51.
32. Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 2009;74:1047-53.
33. Strnad V, Geiger M, Lotter M, Sauer R. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy 2003;2:158-63.
34. Jiang P, Jiang Y, Wang JJ, Meng N, Ran W, Qu A, et al. Percutaneous ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent head and neck carcimonas. Cancer Biother Radiopharm 2011;26:753-7.
35. Vikram B, Hilaris BS, Anderson L, Strong EW. Permanent Iodine-125 implants in head and neck cancer. Cancer 1983;51:1310-4.
36. Mazeron JJ, Langlois D, Glaubiger D, Huart J, Martin M, Raynal M, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 1987;13:957-62.
37. Ashamalla H, Rafla S, Zaki B, Ikoro NC, Ross P. Radioactive gold grain implants in recurrent and locally advanced head-and-neck cancers. Brachytherapy 2002;1:161-6.
38. Puthawala A, Nisar Syed AM, Gamie S, Chen YJ, Londrc A, Nixon V. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Int J Radiat Oncol Biol Phys 2001;51:354-62.
39. Kolotas C, Tselis N, Sommerlad M, Röddiger S, Schnabel T, Baltas D, et al. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Strahlenther Onkol 2007;183:69-75.
40. Toma S, Airoldi M, Palumbo R, Raffo P, Bumma C. Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN). Int J Cancer 1997;70:491-3.
41. Recchia F, Candeloro G, Di Staso M, Necozione S, Bisegna R, Bratta M, et al. Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck. J Immunother 2008;31:413-9.
42. Paiva MB, Bublik M, Castro DJ, Udewitz M, Wang MB, Kowalski LP, et al. Intratumor injections of cisplatin and laser thermal therapy for palliative treatment of recurrent cancer. Photomed Laser Surg 2005;23:531-5.
43. Sercarz JA, Bublik M, Joo J, Paiva PB, Areco KN, Brandalise MH, et al. Outcomes of laser thermal therapy for recurrent head and neck cancer. Otolaryngol Head Neck Surg 2010;14:344-50.
44. Paiva MB, Blackwell KE, Saxton RE, Bublik M, Liu CD, Paiva Paolini AA, et al. Nd:YAG laser therapy for palliation of recurrent squamous cell carcinomas in the oral cavity. Lasers Surg Med 2002;31:64-9.
45. Joo J, Sercarz JA, Paolini AA, Castro DJ, Paiva MB. Laser-induced thermal therapy and cisplatin for recurrent head and neck cancer: a case characterized by an unusually long disease-free survival. Ear Nose Throat J 2009;88:13-6.
46. Paiva MB, Saxton RE, Blackwell KE, Buechler P, Cohen A, Liu CD, et al. Combined cisplatinum and laser thermal therapy for palliation of recurrent head and neck tumors. Diagn Ther Endosc 2000;6:133-40.
47. Hauser U, Hoffmann TK, Balló H, Bier H. Argon plasma coagulation (APC) in palliative surgery of head and neck malignancies. Laryngoscope 2002;112:1275-80.
48. Mai HQ, Mo HY, Deng JF, Deng MQ, Mai WY, Huang XM, et al. Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma. Eur J Cancer 2009;45:1107-10.
49. Owen RP, Khan SA, Negassa A, Beitler JJ, Bello JA, Brook A, et al. Radiofrequency ablation of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2011;137:493-8.
50. Owen RP, Silver CE, Ravikumar TS, Brook A, Bello J, Breining D. Techniques for radiofrequency ablation of head and neck tumors. Arch Otolaryngol Head Neck Surg 2004;130:52-6.
51. Brook AL, Gold MM, Miller TS, Gold T, Owen RP, Sanchez LS, et al. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J Vasc Interv Radiolz 2008;19:725-35.
52. Gleich LL. Gene therapy for head and neck cancer. Laryngoscope 2000;110:708-26.
53. Huang PI, Chang JF, Kirn DH, Liu TC. Targeted genetic and viral therapy for advanced head and neck cancers. Drug Discov Today 2009;14:570-8.
54. Clayman GL, el-Naggar AK, Lippman SM, Henderson YC, Frederick M, Merritt JA, et al. Adenovirus- mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998;16:2221-32.
55. Ganly I, Kirn D, Eckhardt G, Rodriguez GI, Soutar DS, Otto R, et al. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin Cancer Res 2000;6:798-806.
56. Mevio N, Bertino G, Occhini A, Scelsi D, Tagliabue M, Mura F, et al. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results. Tumori 2012;98:308-13.
57. Tijink BM, De Bree R, Van Dongen GA, Leemans CR. How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients. Clin Otolaryngol 2006;31:447-51.
58. Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2005;31:1029-35.
59. Karakullukcu B, Nyst HJ, van Veen RL, Hoebers FJ, Hamming-Vrieze O, Witjes MJ, et al. mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method. Head Neck 2012;34:1597-606.
60. Jerjes W, Upile T, Hamdoon Z, Abbas S, Akram S, Mosse CA, et al. Photodynamic therapy: The minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma. Lasers Surg Med 2011;43:283-92.